ArticleFrontiers in molecular neuroscience2021

Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas.

Liguo Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.